ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma

by Han, A.-Q, Liu, Y., Meng, T., Qian, B., Wang, H.-X, Wang, W., Wang, Z.-Z, Wu, J., Yang, M.-Y, Zhang, Y., Zhu, L.-X
Published 2022

Prognostic serum biomarkers in cancer patients with COVID-19: A systematic review

by Bello, D., Kuo, C.-T, Lai, Y.-J, Lee, T.-A, Li, C.-W, McCullough, L.D, Wang, S.-H
Published 2022

Assessment of salivary gland function after 177Lu-PSMA radioligand therapy: Current concepts in imaging and management

by Friedman, K.P, Grewal, R.K, Mahajan, S., Pandit-Taskar, N., Schöder, H.
Published 2022

Preliminary study on the role of the C5orf46 gene in renal cancer

by Chen, Q., Fu, S., Li, Z., Liu, Y., Ma, M., Wang, S., Zhang, Z.
Published 2022

Machine-learning aided in situ drug sensitivity screening predicts treatment outcomes in ovarian PDX tumors

by Ahn, S., Bashyam, A., Christodoulopoulos, E., Cima, M.J, Cotler, M.J, Ding, H., Hou, X., Jonas, O., Kaufmann, S.H, Larson, M., Oberg, A.L, Ramadi, K.B, Weroha, S.J, Whittaker, C.
Published 2022

Eriodictyol mediated selective targeting of the TNFR1/FADD/TRADD axis in cancer cells induce apoptosis and inhibit tumor progression and metastasis

by Biswas, K., Das, T., Debnath, S., Ghosh, Z., Mahata, B., Mahata, T., Mukherjee, D.D, Mukhopadhyay, R., Parida, P.K, Ray, S., Sarkar, A.
Published 2022

Long non-coding RNA ZNF667-AS1 retards the development of esophageal squamous cell carcinoma via modulation of microRNA-1290-mediated PRUNE2

by Liang, T.-S, Wang, J., Wang, L.-D, Yang, D.-K, Zhai, S.-N, Zhao, J.-Y, Zheng, Y.-J
Published 2022

A novel treatment strategy of HER2-targeted therapy in combination with Everolimus for HR+/HER2- advanced breast cancer patients with HER2 mutations

by Li, M., Li, N., Li, X., Ma, J., Sun, S., Zhang, Q., Zhao, S., Zhao, Z.
Published 2022

A novel multifunctional anti-PD-L1-CD16a-IL15 induces potent cancer cell killing in PD-L1-positive tumour cells

by Feng, X., Huang, B., Li, Y., Liu, Y., Ma, S., Wang, H., Wu, L.
Published 2022

Preoperative red blood cell distribution width as an independent prognostic factor in metastatic renal cell carcinoma

by Gou, X., He, W., Ma, X., Wei, Z., Xie, Y., Zhang, F., Zhang, X.
Published 2022

Correlation of changes in subclonal architecture with progression in the MMRF CoMMpass study

by Farswan, A., Gupta, A., Gupta, R., Jena, L., Kaur, G., Sriram, K.
Published 2022

Quantitative proteomic profiling of hepatocellular carcinoma at different serum alpha-fetoprotein level

by Lin, H., Lu, J., Pan, B., Shu, W., Su, R., Wang, R., Wei, X., Xu, X., Yang, M.
Published 2022

TSPAN31 regulates the proliferation, migration, and apoptosis of gastric cancer cells through the METTL1/CCT2 pathway

by Lu, M., Ma, X., Qiu, S., Song, Q., Tang, X., Wang, J., Wang, P., Wang, Z., Xia, Q., Zhao, Q.
Published 2022

AKR1C1 promotes non-small cell lung cancer proliferation via crosstalk between HIF-1α and metabolic reprogramming

by Chang, L.-L, Hu, Y., Lin, N.-M, Lu, P.-H, Yang, W., Zhang, W.-Z, Zhao, Q., Zheng, L.
Published 2022

PDE4D targeting enhances anti-tumor effects of sorafenib in clear cell renal cell carcinoma and attenuates MAPK/ERK signaling in a CRAF-dependent manner

by Ajay, A.K, Cao, M., Hsiao, L.-L, Jin, Y., Luo, Y., Moench, R., Nawalaniec, K., Waaga-Gasser, A.M, Xiao, S.
Published 2022

Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma

by Banchelli, F., Candini, O., Casari, G., Casarini, L., Chiavelli, C., Cossarizza, A., Dall'Ora, M., D'Amico, R., Dominici, M., Golinelli, G., Grisendi, G., Nasi, M., Prapa, M., Rossignoli, F., Spano, C., Talami, R.
Published 2022

Improved prediction of radiation pneumonitis by combining biological and radiobiological parameters using a data-driven Bayesian network analysis

by Boonstra, P., Green, M.D, Haken, R.T, Hinton, T., Jiang, R., Jolly, S., Karnak, D., Lawrence, T.S, Luo, Y., Matuszak, M., Maurino, C., Nancarrow, D.J, Naqa, I.E, Ray, D., Ray, P., Sandford, E., Schipper, M.J, Schonewolf, C.A, Sun, Y., Tang, M., Tewari, M., Yanik, G.A
Published 2022

Low doses of niclosamide and quinacrine combination yields synergistic effect in melanoma via activating autophagy-mediated p53-dependent apoptosis

by Ding, C., Dong, L., Gao, X., Li, S., Ma, Z., Sun, L., Wang, M., Wang, Y., Zhang, J., Zhang, Y., Zhao, N., Zheng, X.
Published 2022